Cargando…
Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic (18)F-FDG-PET Study
Metabolic syndrome is a condition characterized by a clustering of metabolic abnormalities associated with an increased risk of type 2 diabetes and cardiovascular disease. An impaired insulin-stimulated myocardial glucose metabolism has been shown to be a risk factor for the development of cardiovas...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276995/ https://www.ncbi.nlm.nih.gov/pubmed/35845046 http://dx.doi.org/10.3389/fcvm.2022.924787 |
_version_ | 1784745844252082176 |
---|---|
author | Succurro, Elena Vizza, Patrizia Papa, Annalisa Cicone, Francesco Monea, Giuseppe Tradigo, Giuseppe Fiorentino, Teresa Vanessa Perticone, Maria Guzzi, Pietro Hiram Sciacqua, Angela Andreozzi, Francesco Veltri, Pierangelo Cascini, Giuseppe Lucio Sesti, Giorgio |
author_facet | Succurro, Elena Vizza, Patrizia Papa, Annalisa Cicone, Francesco Monea, Giuseppe Tradigo, Giuseppe Fiorentino, Teresa Vanessa Perticone, Maria Guzzi, Pietro Hiram Sciacqua, Angela Andreozzi, Francesco Veltri, Pierangelo Cascini, Giuseppe Lucio Sesti, Giorgio |
author_sort | Succurro, Elena |
collection | PubMed |
description | Metabolic syndrome is a condition characterized by a clustering of metabolic abnormalities associated with an increased risk of type 2 diabetes and cardiovascular disease. An impaired insulin-stimulated myocardial glucose metabolism has been shown to be a risk factor for the development of cardiovascular disease in patients with type 2 diabetes. Whether cardiac insulin resistance occurs in subjects with metabolic syndrome remains uncertain. To investigate this issue, we evaluated myocardial glucose metabolic rate using cardiac dynamic (18)F-FDG-PET combined with euglycemic-hyperinsulinemic clamp in three groups: a group of normal glucose tolerant individuals without metabolic syndrome (n = 10), a group of individuals with type 2 diabetes and metabolic syndrome (n = 19), and a group of subjects with type 2 diabetes without metabolic syndrome (n = 6). After adjusting for age and gender, individuals with type 2 diabetes and metabolic syndrome exhibited a significant reduction in insulin-stimulated myocardial glucose metabolic rate (10.5 ± 9.04 μmol/min/100 g) as compared with both control subjects (32.9 ± 9.7 μmol/min/100 g; P < 0.0001) and subjects with type 2 diabetes without metabolic syndrome (25.15 ± 4.92 μmol/min/100 g; P = 0.01). Conversely, as compared with control subjects (13.01 ± 8.53 mg/min x Kg FFM), both diabetic individuals with metabolic syndrome (3.06 ± 1.7 mg/min × Kg FFM, P = 0.008) and those without metabolic syndrome (2.91 ± 1.54 mg/min × Kg FFM, P = 0.01) exhibited a significant reduction in whole-body insulin-stimulated glucose disposal, while no difference was observed between the 2 groups of subjects with type 2 diabetes with or without metabolic syndrome. Univariate correlations showed that myocardial glucose metabolism was positively correlated with insulin-stimulated glucose disposal (r = 0.488, P = 0.003), and negatively correlated with the presence of metabolic syndrome (r = −0.743, P < 0.0001) and with its individual components. In conclusion, our data suggest that an impaired myocardial glucose metabolism may represent an early cardio-metabolic defect in individuals with the coexistence of type 2 diabetes and metabolic syndrome, regardless of whole-body insulin resistance. |
format | Online Article Text |
id | pubmed-9276995 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92769952022-07-14 Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic (18)F-FDG-PET Study Succurro, Elena Vizza, Patrizia Papa, Annalisa Cicone, Francesco Monea, Giuseppe Tradigo, Giuseppe Fiorentino, Teresa Vanessa Perticone, Maria Guzzi, Pietro Hiram Sciacqua, Angela Andreozzi, Francesco Veltri, Pierangelo Cascini, Giuseppe Lucio Sesti, Giorgio Front Cardiovasc Med Cardiovascular Medicine Metabolic syndrome is a condition characterized by a clustering of metabolic abnormalities associated with an increased risk of type 2 diabetes and cardiovascular disease. An impaired insulin-stimulated myocardial glucose metabolism has been shown to be a risk factor for the development of cardiovascular disease in patients with type 2 diabetes. Whether cardiac insulin resistance occurs in subjects with metabolic syndrome remains uncertain. To investigate this issue, we evaluated myocardial glucose metabolic rate using cardiac dynamic (18)F-FDG-PET combined with euglycemic-hyperinsulinemic clamp in three groups: a group of normal glucose tolerant individuals without metabolic syndrome (n = 10), a group of individuals with type 2 diabetes and metabolic syndrome (n = 19), and a group of subjects with type 2 diabetes without metabolic syndrome (n = 6). After adjusting for age and gender, individuals with type 2 diabetes and metabolic syndrome exhibited a significant reduction in insulin-stimulated myocardial glucose metabolic rate (10.5 ± 9.04 μmol/min/100 g) as compared with both control subjects (32.9 ± 9.7 μmol/min/100 g; P < 0.0001) and subjects with type 2 diabetes without metabolic syndrome (25.15 ± 4.92 μmol/min/100 g; P = 0.01). Conversely, as compared with control subjects (13.01 ± 8.53 mg/min x Kg FFM), both diabetic individuals with metabolic syndrome (3.06 ± 1.7 mg/min × Kg FFM, P = 0.008) and those without metabolic syndrome (2.91 ± 1.54 mg/min × Kg FFM, P = 0.01) exhibited a significant reduction in whole-body insulin-stimulated glucose disposal, while no difference was observed between the 2 groups of subjects with type 2 diabetes with or without metabolic syndrome. Univariate correlations showed that myocardial glucose metabolism was positively correlated with insulin-stimulated glucose disposal (r = 0.488, P = 0.003), and negatively correlated with the presence of metabolic syndrome (r = −0.743, P < 0.0001) and with its individual components. In conclusion, our data suggest that an impaired myocardial glucose metabolism may represent an early cardio-metabolic defect in individuals with the coexistence of type 2 diabetes and metabolic syndrome, regardless of whole-body insulin resistance. Frontiers Media S.A. 2022-06-29 /pmc/articles/PMC9276995/ /pubmed/35845046 http://dx.doi.org/10.3389/fcvm.2022.924787 Text en Copyright © 2022 Succurro, Vizza, Papa, Cicone, Monea, Tradigo, Fiorentino, Perticone, Guzzi, Sciacqua, Andreozzi, Veltri, Cascini and Sesti. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Succurro, Elena Vizza, Patrizia Papa, Annalisa Cicone, Francesco Monea, Giuseppe Tradigo, Giuseppe Fiorentino, Teresa Vanessa Perticone, Maria Guzzi, Pietro Hiram Sciacqua, Angela Andreozzi, Francesco Veltri, Pierangelo Cascini, Giuseppe Lucio Sesti, Giorgio Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic (18)F-FDG-PET Study |
title | Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic (18)F-FDG-PET Study |
title_full | Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic (18)F-FDG-PET Study |
title_fullStr | Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic (18)F-FDG-PET Study |
title_full_unstemmed | Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic (18)F-FDG-PET Study |
title_short | Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic (18)F-FDG-PET Study |
title_sort | metabolic syndrome is associated with impaired insulin-stimulated myocardial glucose metabolic rate in individuals with type 2 diabetes: a cardiac dynamic (18)f-fdg-pet study |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276995/ https://www.ncbi.nlm.nih.gov/pubmed/35845046 http://dx.doi.org/10.3389/fcvm.2022.924787 |
work_keys_str_mv | AT succurroelena metabolicsyndromeisassociatedwithimpairedinsulinstimulatedmyocardialglucosemetabolicrateinindividualswithtype2diabetesacardiacdynamic18ffdgpetstudy AT vizzapatrizia metabolicsyndromeisassociatedwithimpairedinsulinstimulatedmyocardialglucosemetabolicrateinindividualswithtype2diabetesacardiacdynamic18ffdgpetstudy AT papaannalisa metabolicsyndromeisassociatedwithimpairedinsulinstimulatedmyocardialglucosemetabolicrateinindividualswithtype2diabetesacardiacdynamic18ffdgpetstudy AT ciconefrancesco metabolicsyndromeisassociatedwithimpairedinsulinstimulatedmyocardialglucosemetabolicrateinindividualswithtype2diabetesacardiacdynamic18ffdgpetstudy AT moneagiuseppe metabolicsyndromeisassociatedwithimpairedinsulinstimulatedmyocardialglucosemetabolicrateinindividualswithtype2diabetesacardiacdynamic18ffdgpetstudy AT tradigogiuseppe metabolicsyndromeisassociatedwithimpairedinsulinstimulatedmyocardialglucosemetabolicrateinindividualswithtype2diabetesacardiacdynamic18ffdgpetstudy AT fiorentinoteresavanessa metabolicsyndromeisassociatedwithimpairedinsulinstimulatedmyocardialglucosemetabolicrateinindividualswithtype2diabetesacardiacdynamic18ffdgpetstudy AT perticonemaria metabolicsyndromeisassociatedwithimpairedinsulinstimulatedmyocardialglucosemetabolicrateinindividualswithtype2diabetesacardiacdynamic18ffdgpetstudy AT guzzipietrohiram metabolicsyndromeisassociatedwithimpairedinsulinstimulatedmyocardialglucosemetabolicrateinindividualswithtype2diabetesacardiacdynamic18ffdgpetstudy AT sciacquaangela metabolicsyndromeisassociatedwithimpairedinsulinstimulatedmyocardialglucosemetabolicrateinindividualswithtype2diabetesacardiacdynamic18ffdgpetstudy AT andreozzifrancesco metabolicsyndromeisassociatedwithimpairedinsulinstimulatedmyocardialglucosemetabolicrateinindividualswithtype2diabetesacardiacdynamic18ffdgpetstudy AT veltripierangelo metabolicsyndromeisassociatedwithimpairedinsulinstimulatedmyocardialglucosemetabolicrateinindividualswithtype2diabetesacardiacdynamic18ffdgpetstudy AT cascinigiuseppelucio metabolicsyndromeisassociatedwithimpairedinsulinstimulatedmyocardialglucosemetabolicrateinindividualswithtype2diabetesacardiacdynamic18ffdgpetstudy AT sestigiorgio metabolicsyndromeisassociatedwithimpairedinsulinstimulatedmyocardialglucosemetabolicrateinindividualswithtype2diabetesacardiacdynamic18ffdgpetstudy |